医学
促红细胞生成素
病态的
贫血
机制(生物学)
肾脏疾病
生物信息学
重症监护医学
评论文章
中医药
肾功能
肾
病理生理学
并发症
治疗方法
急性肾损伤
海西定
发病机制
功能(生物学)
炎症
临床实习
临床研究
作者
Jia-Xing Rao,Hao-Ming Zhou,Kim Fey Leu,Ming Liu,Ze-Feng Liu,Yu-Ping Tang
标识
DOI:10.3389/fphar.2026.1847564
摘要
Renal anemia (RA) is a common complication associated with chronic kidney diseases. Its pathological mechanism is attributed to the combined effects of insufficient production of erythropoietin by the kidneys, iron metabolism disorders, and chronic inflammatory conditions. The main pillars of medicine treatment for these aspects include erythropoiesis-stimulating agents, iron supplementation, and novel hypoxia-inducible factor prolyl hydroxylase inhibitors. Traditional Chinese medicine shows potential advantages across multiple targets in improving anemia and renal function in patients with RA. This review aims to systematically explain the current pathophysiological understanding of RA, examine the prevailing treatment approaches, and summarize the pharmacological mechanisms and research findings related to natural products and their active compounds used in RA treatment. This review is to provide new insights and references to support future in-depth research and clinical management of RA.
科研通智能强力驱动
Strongly Powered by AbleSci AI